Trademark: 90875583
Status Date
Wednesday, March 6, 2024
Filing Date
Tuesday, August 10, 2021
Published for Opposition
Tuesday, July 12, 2022
9 Laboratory equipment, namely, microfluidic array plates and optical detection apparatus in the nature of a laboratory instrument for the detection of nucleic acid molecules in a biological sample for research use
5 Kits consisting primarily of medical diagnostic reagents and laboratory equipment being microfluidic array plates for medical use; clinical medical diagnostic reagents being oligonucleotides, primers, enzymes and reaction buffers, sold individually, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications
1 Kits consisting primarily of laboratory and scientific reagents and laboratory equipment being microfluidic array plates for laboratory and scientific research use, other than for medical or veterinary use; laboratory reagents for scientific and research use, namely, oligonucleotides, DNA primers and biochemical probes for detecting and analyzing molecules in protein or nucleotide arrays, enzymes and enzyme mix substrates, nucleotide sets and nucleotide mixes both consisting primarily of nucleotides for scientific and research use, fluorescent reference dye, reaction buffers, sold individually and also sold together as a kit, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction, all of the foregoing for laboratory, scientific and research use
Mar 7, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2024
Sou Extension 3 Granted
Mar 6, 2024
Sou Extension 3 Filed
Mar 6, 2024
Sou Teas Extension Received
Sep 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 6, 2023
Sou Extension 2 Granted
Sep 6, 2023
Sou Extension 2 Filed
Sep 6, 2023
Sou Teas Extension Received
Mar 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 3, 2023
Sou Extension 1 Granted
Mar 3, 2023
Sou Extension 1 Filed
Mar 3, 2023
Sou Teas Extension Received
Sep 6, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2022
Published For Opposition
Jun 22, 2022
Notification Of Notice Of Publication E-Mailed
Jun 7, 2022
Approved For Pub - Principal Register
Jun 7, 2022
Examiner's Amendment Entered
Jun 7, 2022
Notification Of Examiners Amendment E-Mailed
Jun 7, 2022
Examiners Amendment E-Mailed
Jun 7, 2022
Examiners Amendment -Written
May 19, 2022
Teas/Email Correspondence Entered
May 18, 2022
Correspondence Received In Law Office
May 18, 2022
Teas Response To Office Action Received
May 10, 2022
Notification Of Non-Final Action E-Mailed
May 10, 2022
Non-Final Action E-Mailed
May 10, 2022
Non-Final Action Written
May 10, 2022
Assigned To Examiner
Oct 1, 2021
New Application Office Supplied Data Entered
Aug 13, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
